Found: 7
Select item for more details and to access through your institution.
SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 254, doi. 10.1002/hon.63_2630
- By:
- Publication type:
- Article
CLINICAL OUTCOMES FROM VENETOCLAX BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMAS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 535, doi. 10.1002/hon.221_2631
- By:
- Publication type:
- Article
UMBRALISIB MONOTHERAPY DEMONSTRATES EFFICACY AND SAFETY IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA: A MULTICENTER, OPEN‐LABEL, REGISTRATION DIRECTED PHASE 2 STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 182, doi. 10.1002/hon.139_2629
- By:
- Publication type:
- Article
SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 254, doi. 10.1002/hon.63_2630
- By:
- Publication type:
- Article
CLINICAL OUTCOMES FROM VENETOCLAX BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMAS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 535, doi. 10.1002/hon.221_2631
- By:
- Publication type:
- Article
UMBRALISIB MONOTHERAPY DEMONSTRATES EFFICACY AND SAFETY IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA: A MULTICENTER, OPEN‐LABEL, REGISTRATION DIRECTED PHASE 2 STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 182, doi. 10.1002/hon.139_2629
- By:
- Publication type:
- Article
FREQUENCY OF PERFORATION & IMPACT OF BOWEL REST IN AGGRESSIVE NON-HODGKIN LYMPHOMA WITH GASTROINTESTINAL INVOLVEMENT: AN INTERNATIONAL, MULTI-CENTER RETROSPECTIVE STUDY.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 201, doi. 10.1002/hon.2438_64
- By:
- Publication type:
- Article